Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital...

Leica Webinar Announcement: Combining RNAscope™ Technology with Protein Detection: A Multi Omics approach using RNA-Protein Integrated Co-Detection Workflow (ICW) Date: February 23, 2023 Time: 8:00 a.m. (PST), 11:00 a.m. (EST), 5:00...

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head-on – from company founder Rudolf Jung building the first microtome to today’s world-leading...

(Vista, CA – Sep 4, 2022)  Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today...

Leica Biosystems: Powered by Universal Access, the BOND-PRIME Advanced Staining Solution Enables Labs to Seamlessly Adapt to Any Incoming Workflows MELBOURNE, AUS. – Leica Biosystems is launching BOND-PRIME, a premium...